Coherus Oncology (CHRS) Intangibles (2014 - 2026)
Coherus Oncology's Intangibles came in at $26.24 million for Q2 2026, down 9.1% from $28.86 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Intangibles (2014 - 2026) Analysis & Trends
Going back to Q3 2014, Coherus Oncology's Intangibles data covers 43 quarters.
- Intangibles carries a five-year compound annual growth rate of 58.5% (FY2020 to FY2025).
- Going back by year, Intangibles was $28.86 million in FY2024 (-31.1%), $41.87 million in FY2023 (+606.0%), $5.93 million in FY2022 (+66.5%) and $3.56 million in FY2021 (+36.0%).
- The five-year range for quarterly Intangibles is $2.62 million (Q3 2021) to $41.87 million (Q4 2023).
- Year-over-year, Intangibles has declined for three consecutive quarters, with an average decline of 7.3% over the last eight quarters.
- The fastest year-over-year change in Intangibles over five years came in Q4 2023 (growth of 606.0%), and the weakest in Q4 2024 (a decline of 31.1%).
- Business Quant data shows CHRS's Intangibles at $26.24 million (Q1 2026), $26.24 million (Q4 2025) and $28.86 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.54 Bn | 1,195.15 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 650.21 Bn | 570.07 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 508.24 Bn | 476.24 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 360.07 Bn | 323.01 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 312.26 Bn | 285.49 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 285.31 Bn | 259.20 Bn | 13.26 Bn | 38.15 Bn |
| 7 | Amgen | 247.74 Bn | 199.39 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 207.12 Bn | 182.22 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 166.13 Bn | 113.48 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Coherus Oncology | 116.17 Mn | -519.97 Mn | 10.07 Mn | 26.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.24 Mn |
| Mar 31, 2026 | 26.24 Mn |
| Dec 31, 2025 | 26.24 Mn |
| Sep 30, 2025 | 28.86 Mn |
| Jun 30, 2025 | 28.86 Mn |
| Mar 31, 2025 | 28.86 Mn |
| Dec 31, 2024 | 28.86 Mn |
| Sep 30, 2024 | 28.86 Mn |
| Jun 30, 2024 | 28.86 Mn |
| Mar 31, 2024 | 28.86 Mn |
| Dec 31, 2023 | 41.87 Mn |
| Sep 30, 2023 | 28.86 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Dec 31, 2021 | 3.56 Mn |
| Sep 30, 2021 | 2.62 Mn |
| Jun 30, 2021 | 2.62 Mn |
| Mar 31, 2021 | 2.62 Mn |
| Dec 31, 2020 | 2.62 Mn |
| Sep 30, 2020 | 2.62 Mn |
| Jun 30, 2020 | 2.62 Mn |
API Access
Coherus Oncology Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();